Scholars Central

Conference abstractPublished 17 Oct 2016

Therapeutic applications of nicotine

Authors: Noreen Khan-Mayberry

NASA Office of Inspector General, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nicotine has long been regarded as one of the most toxic chemicals/drugs to human health. However, for centuries, it has also been used therapeutically. Recently, investigations into its use for treating diseases such as ADHD, depression, Alzheimer & Parkinson diseases, digestive disorders, pain management and cognitive enhancement, have been eliciting more attention due to the development of non-prescription therapeutic products. Given that the toxicity ofover the counter (OTC) nicotine products for use in cessation of smoking is generally accepted as low-to-none, when used as directed, product developers assume that these same levels are toxicologically safe for non-smoking cessation products. This may be the case, since the bulk of safety assessments for these products (such as electronic cigarettes) only point to risks from mishandling by non-target populations (children, pets, abusers) âÂ?Â? not the levels of nicotine. Given the multiple routes of exposure (inhalation, ingestion and dermal absorption) that are already approved for nicotine replacement therapy (NRC) we explore and debate the best way for Toxicologists to assess non-NRC replacement therapeutic products.

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Toxicology
  • SubjectToxicology
  • BylineArticles whose byline prints “Noreen Khan-Mayberry”